79 related articles for article (PubMed ID: 6534324)
1. New procedure for purification of human platelet-derived growth factor.
Czyrski JA; Narczewska B; Inglot AD
Arch Immunol Ther Exp (Warsz); 1984; 32(5):589-98. PubMed ID: 6534324
[TBL] [Abstract][Full Text] [Related]
2. Partial purification of porcine platelet-derived growth factor (PDGF).
Narczewska B; Czyrski JA
Arch Immunol Ther Exp (Warsz); 1987; 35(6):831-7. PubMed ID: 3508040
[TBL] [Abstract][Full Text] [Related]
3. Properties of purified bovine platelet-derived growth factor stimulating proliferation of human and mouse fibroblasts.
Narczewska B; Czyrski JA; Inglot AD
Can J Biochem Cell Biol; 1985 Mar; 63(3):187-94. PubMed ID: 3986665
[TBL] [Abstract][Full Text] [Related]
4. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells.
Huang Q; Wang YD; Wu T; Jiang S; Hu YL; Pei GX
Chin Med J (Engl); 2009 Jan; 122(1):83-7. PubMed ID: 19187622
[TBL] [Abstract][Full Text] [Related]
5. Biological properties of a hepatocyte growth factor from rat platelets.
Russell WE; McGowan JA; Bucher NL
J Cell Physiol; 1984 May; 119(2):193-7. PubMed ID: 6715417
[TBL] [Abstract][Full Text] [Related]
6. Purification of human platelet-derived growth factor.
Antoniades HN; Scher CD; Stiles CD
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1809-13. PubMed ID: 287022
[TBL] [Abstract][Full Text] [Related]
7. A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets.
Burnouf T; Kuo YP; Huang CT; Tseng YH; Lin CT; Su CY
Transfusion; 2010 Aug; 50(8):1702-11. PubMed ID: 20412527
[TBL] [Abstract][Full Text] [Related]
8. Partial purification and characterization of porcine platelet-derived growth factor (PDGF).
Poggi A; Rucinski B; James P; Holt JC; Niewiarowski S
Exp Cell Res; 1984 Feb; 150(2):436-41. PubMed ID: 6692858
[TBL] [Abstract][Full Text] [Related]
9. Bovine transforming growth factor beta. Purification and characterization.
Popik W; Inglot O
Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):715-24. PubMed ID: 2487381
[TBL] [Abstract][Full Text] [Related]
10. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
Dell'Aquila ML; Pigott DA; Bonaquist DL; Gaffney EV
J Natl Cancer Inst; 1984 Feb; 72(2):291-8. PubMed ID: 6582317
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a bovine colostrum-derived growth factor.
Shing Y; Klagsbrun M
Mol Endocrinol; 1987 May; 1(5):335-8. PubMed ID: 3274892
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional control of protein synthesis in Balb/c-3T3 cells by platelet-derived growth factor and platelet-poor plasma.
Cochran BH; Lillquist JS; Stiles CD
J Cell Physiol; 1981 Dec; 109(3):429-38. PubMed ID: 6798044
[TBL] [Abstract][Full Text] [Related]
13. Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor.
Heldin CH; Westermark B; Wasteson A
J Cell Physiol; 1980 Nov; 105(2):235-46. PubMed ID: 6936400
[TBL] [Abstract][Full Text] [Related]
14. Human platelet-derived growth factor. Purification and resolution into two active protein fractions.
Deuel TF; Huang JS; Proffitt RT; Baenziger JU; Chang D; Kennedy BB
J Biol Chem; 1981 Sep; 256(17):8896-9. PubMed ID: 7263691
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
16. Platelet derived growth factor is present in human placenta: purification from an industrially processed fraction.
Marez A; N'Guyen T; Chevallier B; Clement G; Dauchel MC; Barritault D
Biochimie; 1987 Feb; 69(2):125-9. PubMed ID: 3105601
[TBL] [Abstract][Full Text] [Related]
17. Human serum from platelet-poor plasma for the culture of primary human preadipocytes.
Koellensperger E; von Heimburg D; Markowicz M; Pallua N
Stem Cells; 2006 May; 24(5):1218-25. PubMed ID: 16424400
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix is a source of mitogenically active platelet-derived growth factor.
Field SL; Khachigian LM; Sleigh MJ; Yang G; Vandermark SE; Hogg PJ; Chesterman CN
J Cell Physiol; 1996 Aug; 168(2):322-32. PubMed ID: 8707868
[TBL] [Abstract][Full Text] [Related]
19. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells.
Ogino Y; Ayukawa Y; Kukita T; Koyano K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390
[TBL] [Abstract][Full Text] [Related]
20. Role of stimulation of arachidonic acid release in the proliferative response of 3T3 mouse fibroblasts to platelet-derived growth factor.
Shier WT; Durkin JP
J Cell Physiol; 1982 Aug; 112(2):171-81. PubMed ID: 6811604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
